Global Blood Therapeutics Inc(London Stock Exchange, The : GBT)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.38% | 194.91 | 1.2% | $602.16m | |
| GILD | Gilead Sciences, Inc. | -0.78% | 67.48 | 0.9% | $499.30m | |
| CELG | Celgene Corporation | -0.19% | 69.27 | 1.2% | $492.42m | |
| BIIB | Biogen Inc. | 0.01% | 319.25 | 1.3% | $467.66m | |
| ILMN | Illumina, Inc. | -5.73% | 301.59 | 3.5% | $381.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 338.98 | 2.6% | $298.66m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.45% | 161.07 | 1.9% | $260.54m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.00% | 115.06 | 2.0% | $199.08m | |
| A | Agilent Technologies, Inc. | -3.72% | 62.57 | 1.5% | $185.86m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.25% | 116.36 | 15.4% | $146.77m | |
| LGND | Ligand Pharmaceuticals Incorporated | -3.83% | 148.54 | 23.3% | $139.57m | |
| EXAS | Exact Sciences Corporation | 0.00% | 67.28 | 25.3% | $137.02m | |
| NKTR | Nektar Therapeutics | -0.05% | 37.99 | 5.6% | $122.18m | |
| INCY | Incyte Corporation | -3.40% | 64.25 | 2.5% | $115.74m | |
| TSRO | TESARO, Inc. | -0.41% | 36.68 | 14.4% | $108.95m |
Company Profile
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.